{"pmid":32402433,"title":"Child with liver transplant recovers from COVID-19 infection. A case report.","text":["Child with liver transplant recovers from COVID-19 infection. A case report.","We present the case of a 55-month-old girl who recovered from coronavirus disease 2019 (COVID-19) infection 5 months after undergoing liver transplantation; she had a co-infection with Epstein-Barr virus (EBV). To the best of our knowledge, this is the first case report of a COVID-19 infection in a pediatric patient with liver transplantation. Additionally, this is also the first report of confirmed co-infection between COVID-19 and EBV. On the basis of this case, we suggest that liver transplantation is not associated with COVID-19 symptom severity and development. Moreover, COVID-19 and EBV co-infections do not seem to aggravate the clinical outcome.","Arch Pediatr","Morand, Aurelie","Roquelaure, Bertrand","Colson, Philippe","Amrane, Sophie","Bosdure, Emmanuelle","Raoult, Didier","Lagier, Jean-Christophe","Fabre, Alexandre","32402433"],"abstract":["We present the case of a 55-month-old girl who recovered from coronavirus disease 2019 (COVID-19) infection 5 months after undergoing liver transplantation; she had a co-infection with Epstein-Barr virus (EBV). To the best of our knowledge, this is the first case report of a COVID-19 infection in a pediatric patient with liver transplantation. Additionally, this is also the first report of confirmed co-infection between COVID-19 and EBV. On the basis of this case, we suggest that liver transplantation is not associated with COVID-19 symptom severity and development. Moreover, COVID-19 and EBV co-infections do not seem to aggravate the clinical outcome."],"journal":"Arch Pediatr","authors":["Morand, Aurelie","Roquelaure, Bertrand","Colson, Philippe","Amrane, Sophie","Bosdure, Emmanuelle","Raoult, Didier","Lagier, Jean-Christophe","Fabre, Alexandre"],"date":"2020-05-14T11:00:00Z","year":2020,"_id":"32402433","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.arcped.2020.05.004","keywords":["biliary atresia","covid-19","children","liver graft"],"topics":["Case Report"],"weight":1,"_version_":1666714494689083392,"score":9.490897,"similar":[{"pmid":32500942,"title":"Outcome of COVID-19 in Liver Transplant Recipients: a Preliminary Report from Northwestern Italy.","text":["Outcome of COVID-19 in Liver Transplant Recipients: a Preliminary Report from Northwestern Italy.","Covid-19 pandemic is deeply affecting transplant activity worldwide. It is unclear whether solid organ transplant recipients are at increased risk of developing severe complications and how they should be managed, also concerning immunosuppression. This is a report about the course and management of SARS-CoV-2 infection in liver transplant recipients from a single center in Northwestern Italy in the period March-April 2020. Three patients who were treated at our Institution are reported in details, whereas summary data are provided for those managed at peripheral Hospitals. Presentation varied from asymptomatic to rapidly progressive respiratory failure due to bilateral interstitial pneumonia. Accordingly, treatment and changes to immunosuppression were adapted to the severity of the disease. Overall mortality was 20%, whereas Covid-related mortality was 10%. Two cases of prolonged (> 2 months) viral carriage were observed in two asymptomatic patients who contracted the infection in the early course after transplant. Besides depicting Covid-19 course and possible treatment scenarios in liver transplant patients, these cases are discussed in relation to the changes in our practice prompted by Covid-19 epidemic, with potential implications for other transplant programs.","Transpl Infect Dis","Patrono, Damiano","Lupo, Francesco","Canta, Francesca","Mazza, Elena","Mirabella, Stefano","Corcione, Silvia","Tandoi, Francesco","De Rosa, Francesco Giuseppe","Romagnoli, Renato","32500942"],"abstract":["Covid-19 pandemic is deeply affecting transplant activity worldwide. It is unclear whether solid organ transplant recipients are at increased risk of developing severe complications and how they should be managed, also concerning immunosuppression. This is a report about the course and management of SARS-CoV-2 infection in liver transplant recipients from a single center in Northwestern Italy in the period March-April 2020. Three patients who were treated at our Institution are reported in details, whereas summary data are provided for those managed at peripheral Hospitals. Presentation varied from asymptomatic to rapidly progressive respiratory failure due to bilateral interstitial pneumonia. Accordingly, treatment and changes to immunosuppression were adapted to the severity of the disease. Overall mortality was 20%, whereas Covid-related mortality was 10%. Two cases of prolonged (> 2 months) viral carriage were observed in two asymptomatic patients who contracted the infection in the early course after transplant. Besides depicting Covid-19 course and possible treatment scenarios in liver transplant patients, these cases are discussed in relation to the changes in our practice prompted by Covid-19 epidemic, with potential implications for other transplant programs."],"journal":"Transpl Infect Dis","authors":["Patrono, Damiano","Lupo, Francesco","Canta, Francesca","Mazza, Elena","Mirabella, Stefano","Corcione, Silvia","Tandoi, Francesco","De Rosa, Francesco Giuseppe","Romagnoli, Renato"],"date":"2020-06-06T11:00:00Z","year":2020,"_id":"32500942","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1111/tid.13353","keywords":["covid-19","early infection","immunosuppression","viral carriage"],"topics":["Case Report"],"weight":1,"_version_":1668890966355869697,"score":181.67387},{"pmid":32438464,"title":"COVID-19 and Liver Transplantation: lessons learned from three reported cases.","text":["COVID-19 and Liver Transplantation: lessons learned from three reported cases.","During the COVID-19 pandemic, transplant recipients have been recognized as more susceptible to infection, to have greater severity of disease, and prolonged shedding of this highly transmissible virus.(1) However, there is limited information on the impact of COVID-19 in liver transplant (LT) recipients. We reviewed three reported cases with detailed treatment information from China to better understand the features and associated therapeutic strategies used in transplant recipients with COVID-19.(2-4).","Transpl Infect Dis","Gao, Feng","Zheng, Kenneth I","Gu, Jin-Yang","George, Jacob","Zheng, Ming-Hua","32438464"],"abstract":["During the COVID-19 pandemic, transplant recipients have been recognized as more susceptible to infection, to have greater severity of disease, and prolonged shedding of this highly transmissible virus.(1) However, there is limited information on the impact of COVID-19 in liver transplant (LT) recipients. We reviewed three reported cases with detailed treatment information from China to better understand the features and associated therapeutic strategies used in transplant recipients with COVID-19.(2-4)."],"journal":"Transpl Infect Dis","authors":["Gao, Feng","Zheng, Kenneth I","Gu, Jin-Yang","George, Jacob","Zheng, Ming-Hua"],"date":"2020-05-22T11:00:00Z","year":2020,"_id":"32438464","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1111/tid.13335","locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Case Report"],"weight":1,"_version_":1667521393618583552,"score":179.74628},{"pmid":32243673,"title":"Successful treatment of severe COVID-19 pneumonia in a liver transplant recipient.","text":["Successful treatment of severe COVID-19 pneumonia in a liver transplant recipient.","Coronavirus disease 2019 (COVID-19) pandemic spreads rapidly and may be an increasing challenge for transplant community. Clinical data on COVID-19 infection in transplant population is very limited. Herein we presented the clinical course and outcome of a 50-year-old male post liver transplantation who contracted COVID-19, with subsequent infection of his wife. The process of illness was representative. A therapeutic regime with temporary immunosuppression withdrawal and systemic low-dose corticosteroid as principle was involved in the management of the patient which made him recover from severe COVID-19 pneumonia.","Am J Transplant","Liu, Bin","Wang, Yangzhong","Zhao, Yuanyuan","Shi, Huibo","Zeng, Fanjun","Chen, Zhishui","32243673"],"abstract":["Coronavirus disease 2019 (COVID-19) pandemic spreads rapidly and may be an increasing challenge for transplant community. Clinical data on COVID-19 infection in transplant population is very limited. Herein we presented the clinical course and outcome of a 50-year-old male post liver transplantation who contracted COVID-19, with subsequent infection of his wife. The process of illness was representative. A therapeutic regime with temporary immunosuppression withdrawal and systemic low-dose corticosteroid as principle was involved in the management of the patient which made him recover from severe COVID-19 pneumonia."],"journal":"Am J Transplant","authors":["Liu, Bin","Wang, Yangzhong","Zhao, Yuanyuan","Shi, Huibo","Zeng, Fanjun","Chen, Zhishui"],"date":"2020-04-04T11:00:00Z","year":2020,"_id":"32243673","source":"PubMed","week":"202014|Mar 30 - Apr 05","doi":"10.1111/ajt.15901","keywords":["clinical research/practice","immunosuppressant","infection and infectious agents - viral","infectious disease","liver transplantation/hepatology"],"topics":["Case Report"],"weight":1,"_version_":1666138492104605699,"score":179.07803},{"pmid":32400013,"title":"A case of coronavirus disease 2019-infected liver transplant donor.","text":["A case of coronavirus disease 2019-infected liver transplant donor.","Coronavirus disease 2019 (COVID-19) is a novel infectious disease that continues to spread on a global scale. There has been growing concern about donor-derived transmissions of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Herein, we present the case of a patient who underwent ABO-incompatible living donor liver transplantation without knowing that the liver donor was infected with COVID-19 during the donation procedure. In this case, the donor-derived transmission to the recipient was not identified, and the liver donor was found to be recovering from a COVID-19 infection. The donor-derived transmission was not identified.","Am J Transplant","Hong, Hyo-Lim","Kim, Sung-Han","Choi, Dong Lak","Kwon, Hyun Hee","32400013"],"abstract":["Coronavirus disease 2019 (COVID-19) is a novel infectious disease that continues to spread on a global scale. There has been growing concern about donor-derived transmissions of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Herein, we present the case of a patient who underwent ABO-incompatible living donor liver transplantation without knowing that the liver donor was infected with COVID-19 during the donation procedure. In this case, the donor-derived transmission to the recipient was not identified, and the liver donor was found to be recovering from a COVID-19 infection. The donor-derived transmission was not identified."],"journal":"Am J Transplant","authors":["Hong, Hyo-Lim","Kim, Sung-Han","Choi, Dong Lak","Kwon, Hyun Hee"],"date":"2020-05-14T11:00:00Z","year":2020,"_id":"32400013","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1111/ajt.15997","keywords":["covid-19","liver transplantation"],"topics":["Case Report"],"weight":1,"_version_":1666865855040847872,"score":175.2938},{"pmid":32277591,"title":"Fatal outcome in a liver transplant recipient with COVID-19.","text":["Fatal outcome in a liver transplant recipient with COVID-19.","Liver injury is common in patients with COVID-19, but little is known about its clinical presentation and severity in the context of liver transplant. We describe a case of COVID-19 in a patient who underwent transplant 3 years ago for hepatocellular carcinoma. The patient came to clinic with symptoms of respiratory disease; pharyngeal swabs for severe acute respiratory syndrome coronavirus 2 were positive. His disease progressed rapidly from mild to critical illness and was complicated by several nosocomial infections and multiorgan failure. Despite multiple invasive procedures and rescue therapies, he died from the disease. The management of COVID-19 in the posttransplant setting presents complex challenges, emphasizing the importance of strict prevention strategies.","Am J Transplant","Huang, Jiao-Feng","Zheng, Kenneth I","George, Jacob","Gao, Hai-Nv","Wei, Ru-Nan","Yan, Hua-Dong","Zheng, Ming-Hua","32277591"],"abstract":["Liver injury is common in patients with COVID-19, but little is known about its clinical presentation and severity in the context of liver transplant. We describe a case of COVID-19 in a patient who underwent transplant 3 years ago for hepatocellular carcinoma. The patient came to clinic with symptoms of respiratory disease; pharyngeal swabs for severe acute respiratory syndrome coronavirus 2 were positive. His disease progressed rapidly from mild to critical illness and was complicated by several nosocomial infections and multiorgan failure. Despite multiple invasive procedures and rescue therapies, he died from the disease. The management of COVID-19 in the posttransplant setting presents complex challenges, emphasizing the importance of strict prevention strategies."],"journal":"Am J Transplant","authors":["Huang, Jiao-Feng","Zheng, Kenneth I","George, Jacob","Gao, Hai-Nv","Wei, Ru-Nan","Yan, Hua-Dong","Zheng, Ming-Hua"],"date":"2020-04-12T11:00:00Z","year":2020,"_id":"32277591","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1111/ajt.15909","keywords":["clinical research/practice","immunosuppressant","immunosuppression/immune modulation","infection and infectious agents","infection and infectious agents - viral","liver transplantation/hepatology"],"topics":["Case Report"],"weight":1,"_version_":1666138491629600770,"score":165.03523}]}